awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q49715030-53A8264D-D639-4D17-8EDF-CB707F418E70
Q49715030-53A8264D-D639-4D17-8EDF-CB707F418E70
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49715030-53A8264D-D639-4D17-8EDF-CB707F418E70
Vanadium: A Panacea for Resistance to Oncolytic Immunotherapy?
P2860
Q49715030-53A8264D-D639-4D17-8EDF-CB707F418E70
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49715030-53A8264D-D639-4D17-8EDF-CB707F418E70
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b7b2e3bca4f224ffc4ad9721acfc7f4158cfc2d
P2860
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.